Related Experiment Video
Updated: Aug 9, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Juvenile rheumatoid arthritis, juvenile chronic arthritis, and juvenile spondyloarthropathies
1Consulting Rooms, Windsor, UK.
Insights
Immunogenetics reveal diverse chronic childhood arthritis types. Early-onset pauciarticular disease links to specific HLA types, while methotrexate effectively manages polyarthritis in juvenile rheumatoid arthritis.
Area of Science:
- Pediatric Rheumatology
- Immunogenetics
- Clinical Trial Analysis
Background:
- Chronic arthritis in children exhibits significant heterogeneity.
- Specific human leukocyte antigen (HLA) types, including DRw13-DRw18 and DQw6-DQw18, are associated with persistent pauciarticular disease in early-onset pediatric arthritis.
- DPw2 is identified as an additional susceptibility factor in this subgroup.
Purpose of the Study:
- To explore the immunogenetic basis of chronic childhood arthritis heterogeneity.
- To evaluate the efficacy of methotrexate in managing juvenile rheumatoid arthritis (JRA).
- To review current therapeutic strategies for pediatric arthritis, including immunogenetics and pharmacotherapy.
Main Methods:
- Analysis of immunogenetic markers (HLA typing) in children with chronic arthritis.
- Review of clinical studies on methotrexate efficacy in JRA, comparing different doses and placebo.
- Examination of treatment outcomes for sulfasalazine and corticosteroid therapies (intra-articular, deflazacort, intravenous methylprednisone).
Main Results:
- Specific HLA associations (DRw13-DRw18, DQw6-DQw18, DPw2) identified for persistent pauciarticular JRA.
- Moderate-dose methotrexate demonstrated superiority over lower doses and placebo in controlling polyarthritis in JRA.
- Methotrexate may be particularly beneficial for polyarthritis following a pauciarticular onset.
- Intra-articular corticosteroids are highlighted for pauciarticular disease; deflazacort shows potential calcium-sparing effects; IV methylprednisone considered for severe cases.
Conclusions:
- Immunogenetics play a crucial role in understanding the heterogeneity of chronic childhood arthritis.
- Methotrexate is an effective treatment for polyarticular JRA, especially for those with prior pauciarticular involvement.
- Further standardization of diagnostic criteria for juvenile spondyloarthropathy and psoriatic arthritis is needed, with HLA-B27 being a potential marker for a subset.
Abstract:
Immunogenetics are supporting the marked heterogeneity of chronic arthritis in children. Thus DRw13-DRw18 and DQw6-DQw18 were associated with persistent pauciarticular disease in children with an early onset of disease. Several studies have shown DPw2 as an additional susceptibility factor in this subgroup. Standardization of diagnostic criteria for juvenile onset spondyloarthropathy and psoriatic arthritis is necessary; various studies are in progress, and although HLA-B27 provides the common marker, this may only apply to a small group of juvenile psoriatics who have spondyloarthropathy. In the management of juvenile rheumatoid arthritis, methotrexate in moderate doses has been shown to be superior to lower doses of methotrexate and placebo in controlling polyarthritis. Methotrexate may be of particular value in treating the polyarthritis that follows a pauciarticular onset. The possible value of sulfasalazine in a B27 group with persistent polyarthritis has been suggested. Highlights of corticosteroid therapy were intra-articular injections, particularly in pauciarticular disease, the suggestion that deflazacort has a calcium sparing effect, and the possible role of intravenous methylprednisone in the management of severe disease.
Related Concept Videos
The JAK-STAT Signaling Pathway
Development of the Limb Synovial Joints
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Chronic Inflammation: Introduction

